Scientific Interest(s):
Dr. Beth Glenn is currently an assistant researcher in the UCLA Division of Cancer Prevention and Control Research and School of Public Health. Her main research is in the area of cancer prevention and control among ethnic minority and underserved populations. She has been involved in a number of collaborative research projects since she joined UCLA, including a population-based survey with an ethnically diverse sample of first-degree relatives of prostate cancer patients, an intervention study to increase colorectal cancer screening among first-degree relatives of colorectal cancer patients and an educational intervention to enhance informed decision-making about prostate cancer screening among Latino men. She is leading an ongoing study focused on understanding perceived benefits and barriers to genetic evaluation and testing for breast cancer risk among ethnic minority women.
In addition to her research activities, Glenn, a licensed psychologist, serves as a clinical consultant for the Simms/Mann-UCLA Center for Integrative Oncology.
Selected Cancer-Related Publications:
Glenn B, Bastani R, Reuben D. How important are psychosocial predictors of mammography receipt among older women when immediate access is provided via on-site service? Am J Health Promot. 2006; 20(4): 237-46.
Mullen PD, Allen JD, Glanz K, Fernandez ME, Bowen DJ, Pruitt SL, Glenn BA, Pignone M. Measures used in studies of informed decision making about cancer screening: a systematic review. Ann Behav Med. 2006; 32(3): 188-201.
Bastani R, Maxwell AE, Kagawa-Singer M, Glenn BA, Parada K. Stimulating cancer research in Asian communities and training the next generation of scientists. Cancer. 2005; 104(12 Suppl): 2926-30.
Burns JW, Glenn B, Lofland K, Bruehl S, Harden RN. Stages of change in readiness to adopt a self-management approach to chronic pain: the moderating role of early-treatment stage progression in predicting outcome. Pain. 2005; 115(3): 322-31.
Bastani R, Yabroff KR, Myers RE, Glenn B. Interventions to improve follow-up of abnormal findings in cancer screening. Cancer. 2004; 101(5 Suppl): 1188-200.